(2026). Early brain‐penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1‐related Aicardi‐Goutières syndrome. Clinical & Translational Immunology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Early Brain‐penetrant Immunotherapy Reverses Interferon Signature and Improves Motor Outcome in a Case of ADAR1‐related Aicardi‐Goutières Syndrome."
Clinical & Translational Immunology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Early Brain‐penetrant Immunotherapy Reverses Interferon Signature and Improves Motor Outcome in a Case of ADAR1‐related Aicardi‐Goutières Syndrome."
Clinical & Translational Immunology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.